arginine has been researched along with biie 0246 in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.12) | 18.2507 |
2000's | 55 (61.80) | 29.6817 |
2010's | 29 (32.58) | 24.3611 |
2020's | 4 (4.49) | 2.80 |
Authors | Studies |
---|---|
Dollinger, H; Doods, H; Eberlein, W; Engel, W; Esser, F; Gaida, W; Rudolf, K; Schnorrenberg, G; Wieland, HA | 1 |
Abounader, R; Cadieux, A; Doods, H; Dumont, Y; Hamel, E; Jacques, D; Pheng, LH; Quirion, R; Regoli, D | 1 |
Doods, H; King, PJ; Widdowson, PS; Williams, G | 1 |
Doods, HN; Weiser, T; Wieland, HA | 1 |
Brock, JA; Hardy, TA; Potter, EK; Smith-White, MA | 1 |
Balasubramaniam, A; Ducroc, R; Goumain, M; Herzog, H; Laburthe, M; Lorinet, AM; Rouet-Benzineb, P; Rozé, C; Tsocas, A; Voisin, T | 1 |
Malmström, RE | 2 |
Beauvillain, JC; Chuoï, MM; Croix, D; Jirou-Najou, JL; Knauf, C; Mortreux, G | 1 |
Herzog, H; Potter, EK; Smith-White, MA | 1 |
Lundberg, JN; Malmström, RE; Weitzberg, E | 1 |
Dumont, Y; Fournier, A; Quirion, R; Redrobe, JP | 1 |
Lundberg, JO; Malmström, RE; Weitzberg, E | 1 |
Berglund, MM; Fredriksson, R; Larhammar, D; Salaneck, E | 1 |
Heilig, M; Thorsell, A | 1 |
Beck-Sickinger, AG; Cao, JQ; Colmers, WF; El Bahh, B | 1 |
Chiba, S; Yang, XP | 2 |
Heilig, M; Rimondini, R; Thorsell, A | 2 |
Carvajal, C; Dumont, Y; Gardell, L; Lai, J; Ossipov, MH; Porreca, F; Quirion, R; Zhang, ET | 1 |
Carvalho, AP; Carvalho, CM; Malva, JO; Silva, AP | 1 |
Cox, HM; Herzog, H; Hyland, NP; Sjöberg, F; Tough, IR | 1 |
Kobelt, P; Mönnikes, H; Mronga, S; Rüter, J; Schäfer, MK; Tebbe, JJ | 1 |
Beck-Sickinger, A; Dumont, Y; Fournier, A; Quirion, R; Thakur, M | 1 |
Fang, L; Lin, Q; Ren, Y; Wang, J; Willis, WD; Zou, X | 1 |
Klein, T; Oberhauser, V; Rump, LC; Schwertfeger, E; Stegbauer, J; Vonend, O | 1 |
Grider, JR; Mahavadi, S; Misra, S; Murthy, KS | 1 |
Jiao, Y; Nadler, JV; Timofeeva, O; Tu, B | 1 |
Abbott, CR; Bloom, SR; Ghatei, MA; Kennedy, AR; Neary, NM; Sajedi, A; Small, CJ | 1 |
Dautzenberg, FM; Neysari, S | 1 |
Kimura, N; Luckman, SM; Scott, V; Stark, JA | 1 |
Jackson, DN; Milne, KJ; Noble, EG; Shoemaker, JK | 1 |
Björkman, JA; Ilebekk, A; Nordlander, M | 1 |
Balosso, S; Beck-Sickinger, AG; Colmers, WF; El Bahh, B; Gehlert, DR; Hamilton, T; Herzog, H; Sperk, G; Vezzani, A | 1 |
Herzog, H; Holzer, P; Painsipp, E; Sperk, G; Thoeringer, CK; Wultsch, T | 1 |
Buus, CL; Frøbert, O; Gradin, KA; Li, JY; Simonsen, U | 1 |
Arban, R; Bacchi, F; Caberlotto, L; Gerrard, P; Jiménez, P; Mathé, AA; Stasi, L | 1 |
Herzog, H; Jiao, Y; Nadler, JV; Tu, B | 1 |
Beck-Sickinger, AG; Bernhardt, G; Brennauer, A; Buschauer, A; Cabrele, C; Schneider, E; Ziemek, R | 1 |
Aspelin, T; Björkman, JA; Eriksen, M; Ilebekk, A; Lyberg, T; Nordlander, M; Sevre, K | 1 |
Ishida, H; Iwata, M; Katayama, S; Kawahara, R; Nakagome, K; Shirayama, Y; Yamamoto, A | 1 |
Adewale, AS; Macarthur, H; Westfall, TC | 1 |
Balasubramaniam, A; Parker, MS; Parker, SL; Sallee, FR | 1 |
Buckholz, TM; Claus, TH; DeCarr, LB; Livingston, JN; Lumb, KJ; Mahle, CD; Mays, MR; Milardo, LF; Ortiz, AA | 1 |
Aguilar, E; Castellano, JM; Fernández-Fernández, R; Pinilla, L; Roa, J; Tena-Sempere, M | 1 |
Danson, EJ; Heaton, DA; Herring, N; Lokale, MN; Paterson, DJ | 1 |
Hao, S; Raybould, HE; Sternini, C | 1 |
Balducci, C; Carli, M; During, MJ; Kanter-Schlifke, I; Kokaia, M; Noe, F; Sørensen, AT; Vezzani, A | 1 |
Körner, M; Reubi, JC | 1 |
During, MJ; Kanter-Schlifke, I; Kokaia, M; Lin, EJ; Sørensen, AT | 1 |
Cox, HM | 1 |
Bai, GY; Han, JH; Kim, SH; Park, WH; Piao, FL; Yuan, K | 1 |
Adame, A; Crews, L; Gage, FH; Hersh, LB; Mante, M; Marr, RA; Masliah, E; Potkar, R; Rockenstein, E; Rose, JB; Spencer, B | 1 |
Barnes, AA; Barton, N; Biagetti, M; Bianchi, F; Blowers, SM; Caberlotto, L; Emmons, A; Holmes, IP; Lunniss, GE; Montanari, D; Norris, R; Walters, DJ; Watson, SP | 1 |
Adams-Deutsch, T; Heilig, M; Nair, SG; Navarre, BM; Pickens, CL; Shaham, Y | 1 |
Brothers, SP; Cameron, M; Chase, P; Hodder, PS; McDonald, P; Mercer, BA; Saldanha, SA; Spicer, TP; Wahlestedt, C | 1 |
Gourcerol, G; Larauche, M; Million, M; Taché, Y; Wang, L; Wu, SV; Yuan, PQ | 1 |
Akerberg, H; Boukharta, L; Fällmar, H; Gutiérrez-de-Terán, H; Larhammar, D; Lundell, I; Mohell, N; Sjödin, P | 1 |
Abe, K; Everhart, L; Jönsson-Rylander, AC; Kitlinska, J; Kuan-Celarier, A; Kuo, L; Li, L; Lu, C; Munivenkatappa, RB; Sun, CC; Sun, J; Tilan, J; Toretsky, JA; Zukowska, Z | 1 |
Körner, M; Reubii, JC; Thalmann, GN; Waser, B | 1 |
Kostić, S; Puljak, L; Sapunar, D; Vukojević, K | 1 |
Bose, SC; Corder, G; Donahue, RR; Solway, B; Taylor, BK | 1 |
Bastianetto, S; Benoit, CE; Dumont, Y; Flores, G; Fournier, A; Morales-Medina, JC; Quirion, R | 1 |
Haas, P; Le, TP; Nave, H; Stadler, J | 1 |
Janssen, P; Rotondo, A; Tack, J; Verschueren, S | 1 |
Cox, HM; Forbes, S; Herzog, H | 1 |
Clark, ES; Flannery, BM; Pestka, JJ | 1 |
Cavadas, C; Cortez, V; Estrada, M; Gonçalves, A; Marques, AP; Rosmaninho-Salgado, J; Santana, MM | 1 |
Menard, JL; Trent, NL | 1 |
De Lima, TC; dos Santos, VV; Farina, M; Lach, G; Prediger, RD; Rodrigues, AL; Santos, DB | 1 |
Ai, J; Cai, BZ; Chen, QX; Liu, J; Sun, LH; Wang, N; Xie, F; Yang, BF; Ye, JH | 1 |
Carmichael, CY; George, O; Gilpin, NW; Kallupi, M; Koob, GF; Vendruscolo, LF | 1 |
Bartness, TJ; Teubner, BJ | 1 |
Ai, J; Niu, HF; Xie, F; Xu, L; Yan, Y; Yang, BF | 1 |
Berthoud, HR; Drucker, DJ; Hao, Z; Morrison, CD; Mumphrey, MB; Münzberg, H; Patterson, LM; Stylopoulos, N; Townsend, RL; Ye, J | 1 |
Cho, IJ; Kim, SC; Lee, BH; Wu, Y; Xu, Y; Yang, CH; Zhang, J; Zhao, R; Zhao, Z | 1 |
Beck-Sickinger, AG; Burkert, K; Kaiser, A; Meier, R; Meiler, J; Mittapalli, GK; Roberts, E; Stichel, J; Zellmann, T | 1 |
Kornhuber, J; Zoicas, I | 3 |
Cheng, G; Ding, X; Jia, T; Kou, X; Zhang, X; Zhang, Y | 1 |
Fujitsuka, N; Hattori, T; Mogami, S; Yamada, C | 1 |
Appel, CK; Christiansen, SH; Diaz-delCastillo, M; Falk, S; Heegaard, AM; Woldbye, DPD | 1 |
Carr, JA; Harris, BN; Islam, R; Prater, CM | 1 |
Bai, Y; Becker, S; Cortes-Burgos, LA; Croll, SD; Eckersdorff, MM; Macdonald, LE; Ruiz, HH | 1 |
Atan, D; Barrington, AF; Butler, MJ; Coward, RJM; Graham, M; Heesom, KJ; Herbert, E; Hurcombe, JA; Ju, W; Kretzler, M; Lay, AC; Lewis, PA; McArdle, CA; Mountjoy, E; Nair, V; Neal, CR; Nelson, RG; Perrett, RM; Ramnath, RD; Satchell, SC; Welsh, GI; Wilson, MC | 1 |
Ikeda, H; Kamata, T; Kamei, J; Ueda, D; Waddington, JL; Yonemochi, N | 1 |
Cimarosti, H; de Lima, TCM; Linartevichi, VF; Soares, ES; Vanz, F | 1 |
1 review(s) available for arginine and biie 0246
Article | Year |
---|---|
Brain neuropeptide Y (NPY) in stress and alcohol dependence.
Topics: Alcoholism; Animals; Anxiety; Arginine; Behavior, Animal; Benzazepines; Brain; Depression; Disease Models, Animal; DNA-Binding Proteins; Gene Expression; Genetic Heterogeneity; Humans; Neuropeptide Y; Receptors, Neuropeptide Y; Stress, Physiological | 2002 |
88 other study(ies) available for arginine and biie 0246
Article | Year |
---|---|
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Male; Muscle Contraction; Neuropeptide Y; Radioligand Assay; Rats; Receptors, Neuropeptide Y; Tumor Cells, Cultured; Vas Deferens | 1999 |
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.
Topics: Animals; Arginine; Autoradiography; Benzazepines; Brain Chemistry; Callithrix; Cell Line; Colon; Dogs; Female; Humans; In Vitro Techniques; Male; Membranes; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swine; Transfection; Vas Deferens | 2000 |
Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.
Topics: Animals; Arginine; Benzazepines; Hypothalamus; In Vitro Techniques; Male; Neuropeptide Y; Potassium; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Electrophysiology; Hippocampus; In Vitro Techniques; Male; Neural Inhibition; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Receptors, Presynaptic; Synapses | 2000 |
Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions.
Topics: Acetylcholine; Action Potentials; Animals; Arginine; Benzazepines; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Neuroeffector Junction; Purines; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Trachea; Vas Deferens | 2001 |
The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Benzazepines; CHO Cells; Cricetinae; Cyclic AMP; DNA, Complementary; Hippocampus; Jejunum; Male; Molecular Sequence Data; Peptide YY; Rats; Rats, Wistar; Receptors, Gastrointestinal Hormone; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Topics: Animals; Arginine; Benzazepines; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Kidney; Male; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Spleen; Swine; Vasoconstriction | 2001 |
Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
Topics: Amides; Animals; Arginine; Benzazepines; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Spleen; Swine | 2001 |
Involvement of NPY Y2 receptor subtype in the control of the spontaneous NO/GnRH release at the rat median eminence.
Topics: Animals; Anti-Anxiety Agents; Arginine; Benzazepines; Endothelium, Vascular; Estrous Cycle; Female; Gonadotropin-Releasing Hormone; Median Eminence; Neuropeptide Y; Nitric Oxide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission.
Topics: Animals; Arginine; Benzazepines; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Heart; Mice; Mice, Knockout; Myocardium; Neuropeptide Y; Neurotransmitter Agents; Parasympathetic Nervous System; Peptide Fragments; Receptors, Neuropeptide Y; Vagus Nerve | 2002 |
Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Topics: Animals; Arginine; Benzazepines; Electric Stimulation; Female; Heart Rate; Kidney; Male; Neural Inhibition; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Peptide YY; Receptors, Neuropeptide Y; Renal Circulation; Spleen; Swine; Sympathetic Nervous System; Yohimbine | 2002 |
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Arginine; Benzazepines; Depression; Drug Evaluation, Preclinical; Immobilization; Male; Mice; Motor Activity; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y; Swimming | 2002 |
Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.
Topics: Animals; Arginine; Benzazepines; Blood Flow Velocity; Blood Pressure; Electric Stimulation; Female; Heart Rate; Kidney; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Renal Circulation; Reserpine; Spleen; Swine; Sympathetic Nervous System | 2002 |
Reciprocal mutations of neuropeptide Y receptor Y2 in human and chicken identify amino acids important for antagonist binding.
Topics: Amino Acid Sequence; Animals; Arginine; Benzazepines; Binding Sites; Cattle; Chickens; Glutamine; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Neuropeptide Y; Receptors, Neuropeptide Y; Rhodopsin; Sequence Alignment; Transfection | 2002 |
Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
Topics: Animals; Arginine; Benzazepines; Dose-Response Relationship, Drug; Electric Stimulation; Epilepsy; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Neuropeptide Y; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synaptic Transmission | 2002 |
Antagonistic interaction between BIIE 0246, a neuropeptide Y Y2-receptor antagonist, and omega-conotoxin GVIA, a Ca2+ channel antagonist, in presynaptic transmitter releases in dog splenic arteries.
Topics: Animals; Arginine; Benzazepines; Calcium Channel Blockers; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Neurotransmitter Agents; omega-Conotoxin GVIA; Presynaptic Terminals; Receptors, Neuropeptide Y; Splenic Artery; Vasoconstriction | 2002 |
Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats.
Topics: Alcohol Drinking; Animals; Arginine; Benzazepines; Conditioning, Operant; Ethanol; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Self Administration | 2002 |
Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y.
Topics: Animals; Arginine; Benzazepines; Disease Models, Animal; Disease Progression; Ganglia, Spinal; Hyperalgesia; Immune Sera; Ligation; Lumbosacral Region; Male; Medulla Oblongata; Microinjections; Nerve Crush; Neuropeptide Y; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Rhizotomy; Spinal Cord; Spinal Nerves | 2002 |
Neuropeptide Y inhibits double peaked vasoconstrictor responses to periarterial nerve stimulation primarily through prejunctional Y2 receptor subtype in canine splenic arteries.
Topics: Animals; Arginine; Benzazepines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Nerve Fibers; Neuropeptide Y; Receptors, Neuropeptide Y; Splenic Artery; Vasoconstriction | 2002 |
Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Topics: Animals; Arginine; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclohexanes; Drug Interactions; Glutamic Acid; Hippocampus; Ionomycin; Ionophores; Neurons; Neuropeptide Y; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptide Fragments; Potassium Chloride; Rats; Rats, Wistar; Receptor Cross-Talk; Receptors, Neuropeptide Y; Synaptosomes; Xanthenes | 2003 |
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Topics: Animals; Arginine; Benzazepines; Colon; Electric Stimulation; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Sex Characteristics; Tetrodotoxin | 2003 |
Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Benzazepines; Corticotropin-Releasing Hormone; Excitatory Amino Acid Agonists; Gastric Acid; Kainic Acid; Male; Microinjections; Neurons; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y | 2003 |
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Topics: Alanine; Aminoisobutyric Acids; Animals; Arginine; Benzazepines; Brain; Carbon Radioisotopes; Cell Line; Iodine Radioisotopes; Male; Naphthalenes; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides, Cyclic; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substrate Specificity; Time Factors; Transformation, Genetic | 2003 |
Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin.
Topics: Animals; Arginine; Benzazepines; Bicuculline; Capsaicin; Foot; GABA Antagonists; Inflammation; Injections, Spinal; Laser-Doppler Flowmetry; Male; Pain; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Skin; Spinal Cord; Sympathectomy; Sympathetic Nervous System | 2004 |
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Topics: Acetylcholine; Aged; Aged, 80 and over; Arginine; Atrial Appendage; Benzazepines; Electric Stimulation; Female; Heart Failure; Humans; Male; Middle Aged; Neuropeptide Y; Presynaptic Terminals; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Vasodilator Agents | 2004 |
Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Topics: Animals; Arginine; Benzazepines; Calcium Channels; Cyclic AMP; Dose-Response Relationship, Drug; Muscle Contraction; Muscle, Smooth; Muscles; Neuropeptide Y; Peptide Fragments; Peptide YY; Pertussis Toxin; Protein Binding; Rabbits; Radioimmunoassay; Receptors, Neuropeptide Y; Signal Transduction; Time Factors | 2005 |
Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Topics: Alcoholism; Animals; Arginine; Benzazepines; Brain; Brain Chemistry; Disease Models, Animal; Ethanol; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Self Administration | 2005 |
Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain.
Topics: 2-Amino-5-phosphonovalerate; Animals; Arginine; Benzazepines; Bicuculline; Convulsants; Dentate Gyrus; Excitatory Postsynaptic Potentials; Hippocampus; Male; Mossy Fibers, Hippocampal; Neuropeptide Y; Patch-Clamp Techniques; Perforant Pathway; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide Y; Status Epilepticus; Synaptic Transmission; Tetrodotoxin | 2005 |
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Topics: Animals; Appetite; Arcuate Nucleus of Hypothalamus; Arginine; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Eating; Male; Neurons; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Satiation | 2005 |
Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Kinetics; Ligands; Mice; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Transfection | 2005 |
Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour.
Topics: Animals; Arginine; Benzazepines; Eating; Fasting; Feeding Behavior; Injections, Intravenous; Male; Peptide Fragments; Peptide YY; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Satiety Response | 2005 |
Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats.
Topics: Aminopeptidases; Animals; Arginine; Benzazepines; Enzyme Inhibitors; Female; Hindlimb; Male; Mercaptoethanol; Muscle, Skeletal; Neuropeptide Y; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Regional Blood Flow | 2005 |
Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
Topics: Animals; Arginine; Benzazepines; Blood Pressure; Catecholamines; Dogs; Electric Stimulation; Heart; Heart Rate; Myocardium; Nerve Fibers; Neuropeptide Y; Parasympathetic Nervous System; Receptors, Neuropeptide Y; Sympathetic Nervous System; Time Factors; Vagus Nerve | 2005 |
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
Topics: Animals; Anticonvulsants; Arginine; Autoradiography; Benzazepines; Electric Stimulation; Electroencephalography; Electrophysiology; Excitatory Amino Acid Agonists; Hippocampus; In Vitro Techniques; Kainic Acid; Magnesium; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Seizures; Synapses | 2005 |
Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.
Topics: Analysis of Variance; Animals; Arginine; Benzazepines; Brain Stem; Cell Count; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Transporter 3; Female; Gastric Acid; Gastric Emptying; Gastric Mucosa; Hydrochloric Acid; Hydrogen-Ion Concentration; Immunohistochemistry; Mice; Mice, Knockout; Neurons; Neuropeptide Y; Peptide Fragments; Peptide YY; Proto-Oncogene Proteins c-fos; Receptors, Neuropeptide Y | 2005 |
Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Topics: Animals; Arginine; Benzazepines; Blood Pressure; Blotting, Western; Electric Stimulation; Female; Hypertension; Immunohistochemistry; Mesenteric Arteries; Neuropeptide Y; Peripheral Vascular Diseases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Vasoconstriction; Vasodilation | 2006 |
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Arginine; Benzazepines; Male; Motor Activity; Rats; Receptors, Neuropeptide Y | 2006 |
Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Topics: Animals; Arginine; Benzazepines; Convulsants; Dentate Gyrus; Epilepsy, Temporal Lobe; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mossy Fibers, Hippocampal; Neuronal Plasticity; Neuropeptide Y; Organ Culture Techniques; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Species Specificity; Status Epilepticus; Synaptic Transmission | 2006 |
Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Topics: Aequorin; Animals; Apoproteins; Arginine; Benzazepines; Binding, Competitive; Calcium Signaling; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; GTP-Binding Protein alpha Subunits, Gq-G11; Ligands; Microscopy, Confocal; Neuropeptide Y; Peptide Fragments; Peptide YY; Protein Binding; Radioligand Assay; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Recombinant Proteins; Reproducibility of Results; Spectrometry, Fluorescence; Swine; Transfection | 2006 |
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246.
Topics: Animals; Arginine; Benzazepines; Biomarkers; Blood Pressure; Body Temperature; Carbon Dioxide; Cardiac Output; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Female; Heart Rate; Hematocrit; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxygen; Potassium; Receptors, Neuropeptide Y; Swine; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Topics: Animals; Antidepressive Agents; Arginine; Avoidance Learning; Behavior, Animal; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Helplessness, Learned; Hippocampus; Injections, Intraventricular; Male; Neuropeptide Y; Peptide YY; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2007 |
Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Topics: Animals; Arginine; Benzazepines; Dopamine; Male; Naphthalenes; Neostriatum; Neuropeptide Y; Peptide Fragments; Peptide YY; Potassium Chloride; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stimulation, Chemical; Synaptic Transmission; Tyrosine | 2007 |
Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins.
Topics: Animals; Arginine; Benzazepines; CHO Cells; Cricetinae; Cricetulus; Dimerization; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Pertussis Toxin; Protein Subunits; Receptors, Neuropeptide Y; Solubility | 2007 |
A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Topics: Adiponectin; Animals; Appetite Depressants; Arginine; Benzazepines; Body Weight; Dose-Response Relationship, Drug; Eating; Glucose; Humans; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptide YY; Polyethylene Glycols; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2007 |
Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat.
Topics: Animals; Arginine; Benzazepines; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Hypothalamus; Luteinizing Hormone; Male; Neuropeptide Y; Orchiectomy; Peptide Fragments; Peptide YY; Random Allocation; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Secretory Rate | 2007 |
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Topics: Acetylcholine; Animals; Arginine; Benzazepines; Bradycardia; Carbachol; Choline O-Acetyltransferase; Cyclic AMP-Dependent Protein Kinases; Female; Guinea Pigs; Heart Rate; Immunohistochemistry; Isoquinolines; Neuropeptide Y; Protein Kinase C; Receptors, Neuropeptide Y; Signal Transduction; Sinoatrial Node; Sulfonamides; Vagus Nerve | 2008 |
Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands.
Topics: Animals; Arginine; Benzazepines; Chemokines, CC; Devazepide; Gastrointestinal Tract; Hormone Antagonists; Injections; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Phenylthiourea; Proto-Oncogene Proteins c-fos; Quaternary Ammonium Compounds; Receptors, Cholecystokinin; Receptors, G-Protein-Coupled; Receptors, Gastrointestinal Hormone; Solitary Nucleus; Vagus Nerve | 2008 |
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.
Topics: Animals; Arginine; Benzazepines; Dependovirus; Discrimination, Psychological; Excitatory Postsynaptic Potentials; Genetic Therapy; Genetic Vectors; Hippocampus; Injections; Long-Term Potentiation; Male; Memory Disorders; Neuronal Plasticity; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Transduction, Genetic; Transgenes | 2008 |
Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Topics: Arginine; Autoradiography; Benzazepines; Binding, Competitive; Brain Neoplasms; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Iodine Radioisotopes; Peptides; Protein Binding; Receptors, Neuropeptide Y; Tissue Distribution | 2008 |
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum.
Topics: Animals; Animals, Newborn; Arginine; Benzazepines; Biophysical Phenomena; Chi-Square Distribution; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; Genetic Vectors; Glutamic Acid; Green Fluorescent Proteins; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Picrotoxin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tetrodotoxin; Transgenes | 2008 |
Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon.
Topics: Aged; Animals; Arginine; Benzazepines; Colon; Female; Humans; Intestinal Absorption; Male; Mice; Mice, Knockout; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y | 2008 |
Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors.
Topics: Animals; Arginine; Atrial Natriuretic Factor; Benzazepines; Gene Expression Regulation; Pancreatic Polypeptide; Peptide YY; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2008 |
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Arginine; Benzazepines; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Genetic Vectors; Humans; Mice; Mice, Transgenic; Neprilysin; Nerve Degeneration; Nerve Growth Factors; Neurons; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y | 2009 |
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
Topics: Amides; Animals; Arginine; Benzazepines; Chemistry, Organic; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Models, Chemical; Peptide Fragments; Protein Binding; Rats; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2009 |
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
Topics: Acoustic Stimulation; Animals; Arginine; Benzazepines; Conditioning, Operant; Corticotropin-Releasing Hormone; Fear; Male; Neuropeptide Y; Pyridazines; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y; Synaptic Transmission; Thiazoles; Time Factors | 2009 |
Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Blood-Brain Barrier; Cell Line; Drug Evaluation, Preclinical; Drug Stability; Heterocyclic Compounds; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Ligands; Mice; Mice, Inbred C57BL; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2010 |
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Arginine; Benzazepines; Bethanechol; Colon; Consciousness; Diarrhea; Eating; Efferent Pathways; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Mice, Inbred C57BL; Myenteric Plexus; Neuropeptide Y; Parasympathomimetics; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Restraint, Physical; Stress, Physiological | 2010 |
Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
Topics: Arginine; Benzazepines; Binding Sites; Humans; Ligands; Mutagenesis, Site-Directed; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2010 |
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Topics: Animals; Apoptosis; Arginine; Benzazepines; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neuroblastoma; Neuropeptide Y; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2010 |
High expression of NPY receptors in the human testis.
Topics: Adult; Arginine; Benzazepines; Binding, Competitive; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Leydig Cells; Male; Middle Aged; Receptors, Neuropeptide Y; Seminoma; Teratoma; Testicular Neoplasms; Testis; Young Adult | 2011 |
Attenuation of pain-related behavior evoked by injury through blockade of neuropeptide Y Y2 receptor.
Topics: Analysis of Variance; Animals; Arginine; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Motor Activity; Neuralgia; Neurons; Neuropeptide Y; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Rotarod Performance Test; Spinal Cord | 2011 |
Tonic inhibition of chronic pain by neuropeptide Y.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Chronic Disease; Gene Expression Regulation; Mice; Mice, Knockout; Neuropeptide Y; Nociceptors; Pain; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Receptors, Neuropeptide Y; Synaptic Transmission | 2011 |
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Arginine; Autoradiography; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Exploratory Behavior; Hippocampus; Interpersonal Relations; Male; Neuropeptide Y; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming; Time Factors | 2012 |
Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels.
Topics: Animals; Arginine; Benzazepines; Cells, Cultured; Cytokines; Endotoxemia; Leukocytes; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Inbred Lew; Receptors, Neuropeptide Y | 2011 |
Role of Y(2) receptors in the regulation of gastric tone in rats.
Topics: Animals; Arginine; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Muscle Tonus; Peptide Fragments; Peptide YY; Piperazines; Rats; Rats, Wistar; Receptors, Gastrointestinal Hormone; Stomach | 2012 |
A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress.
Topics: Animals; Arginine; Benzazepines; Corticosterone; Eating; Female; Gastrointestinal Motility; Gastrointestinal Tract; Male; Mice; Mice, Knockout; Neuropeptide Y; Restraint, Physical; Sex Factors; Stress, Physiological | 2012 |
Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.
Topics: Administration, Oral; Animals; Anorexia; Appetite Depressants; Appetite Regulation; Arginine; Behavior, Animal; Benzazepines; Chemokines, CC; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Eating; Female; Food Contamination; Injections, Intraperitoneal; Mice; Mycotoxins; Peptide YY; Receptors, Cholecystokinin; Receptors, Neuropeptide Y; Satiation; Time Factors; Trichothecenes | 2012 |
Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Arginine; Benzazepines; Cell Differentiation; Cell Proliferation; Coloring Agents; Lipid Metabolism; Mice; Neuropeptide Y; PPAR gamma; Protein Kinase Inhibitors; Receptors, Neuropeptide Y | 2012 |
Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Topics: Agonistic Behavior; Animals; Anxiety; Appetite; Arginine; Benzazepines; Dose-Response Relationship, Drug; Eating; Electroshock; Injections; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Septum of Brain | 2013 |
Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
Topics: Amyloid beta-Peptides; Animals; Arginine; Benzazepines; Cerebral Cortex; Depression; Glutathione; Glutathione Peroxidase; Hippocampus; Injections, Intraventricular; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Mice; Motor Activity; Neuropeptide Y; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Receptors, Neuropeptide Y | 2013 |
Blockage of peripheral NPY Y1 and Y2 receptors modulates barorefex sensitivity of diabetic rats.
Topics: Animals; Arginine; Baroreflex; Benzazepines; Blood Pressure; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Experimental; Heart Rate; Hyperlipidemias; Male; Neuropeptide Y; Nitroprusside; Phenylephrine; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Triglycerides | 2013 |
Neuropeptide YY(2)R blockade in the central amygdala reduces anxiety-like behavior but not alcohol drinking in alcohol-dependent rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Benzamides; Benzazepines; Central Amygdaloid Nucleus; Central Nervous System Depressants; Ethanol; Male; Piperazines; Rats, Wistar; Receptors, Neuropeptide Y; Reinforcement Schedule; Reinforcement, Psychology | 2014 |
PYY(3-36) into the arcuate nucleus inhibits food deprivation-induced increases in food hoarding and intake.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Benzazepines; Catheterization; Cricetinae; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Food Deprivation; Injections, Intraventricular; Male; Peptide YY; Phodopus; Receptors, Neuropeptide Y; Stereotaxic Techniques | 2013 |
Inhibition of peripheral NPY Y1 and Y2 receptors ameliorates the aberrant baroreceptor reflex sensitivity in streptozotocin induced diabetic rats.
Topics: Animals; Arginine; Baroreflex; Benzazepines; Blood Pressure; Bradycardia; Diabetes Mellitus, Experimental; Heart Rate; Myocardial Contraction; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Streptozocin | 2013 |
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.
Topics: Animals; Arginine; Benzazepines; Body Composition; Body Weight; Dietary Fats; Eating; Energy Metabolism; Gastric Bypass; Glucagon-Like Peptide-1 Receptor; Male; Mice; Mice, Knockout; Motor Activity; Obesity; Oxygen Consumption; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Weight Loss | 2014 |
Involvement of amygdaloid neuropeptide Y in the anxiolytic effects of acupuncture during ethanol withdrawal in rats.
Topics: Acupuncture Therapy; Amygdala; Animals; Anxiety; Arginine; Benzazepines; Cyclic AMP Response Element-Binding Protein; Ethanol; Male; Maze Learning; Neuropeptide Y; Phosphorylation; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2014 |
A Deep Hydrophobic Binding Cavity is the Main Interaction for Different Y
Topics: Animals; Arginine; Benzazepines; Binding Sites; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Molecular Structure; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2017 |
Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice.
Topics: Animals; Arginine; Benzazepines; Brain; Discrimination, Psychological; Infusions, Intraventricular; Male; Memory; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Social Behavior | 2017 |
Leptin siRNA promotes ovarian granulosa cell apoptosis and affects steroidogenesis by increasing NPY2 receptor expression.
Topics: Androstenedione; Animals; Apoptosis; Arginine; Benzazepines; Cell Proliferation; Dinoprostone; Female; Follicle Stimulating Hormone; Gene Knockdown Techniques; Gonadal Steroid Hormones; Granulosa Cells; Humans; Janus Kinase 2; Leptin; Mice; Mice, Inbred C57BL; Neuropeptide Y; Progesterone; Receptors, Neuropeptide Y; RNA, Small Interfering; STAT3 Transcription Factor | 2017 |
Peptide YY induces characteristic meal patterns of aged mice.
Topics: Aging; Animals; Appetite; Arginine; Benzazepines; Eating; Feeding Behavior; Male; Mice; Mice, Inbred C57BL; Peptide YY; Receptors, Neuropeptide Y | 2017 |
Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Cancer Pain; Female; Male; Musculoskeletal Pain; Neuropeptide Y; Nociception; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Spinal Cord Dorsal Horn | 2018 |
Neuroendocrine modulation of predator avoidance/prey capture tradeoffs: Role of tectal NPY2R receptors.
Topics: Animals; Arginine; Benzazepines; Feeding Behavior; Female; Neuropeptide Y; Neurosecretory Systems; Predatory Behavior; Receptors, Neuropeptide Y; Superior Colliculi; Swine; Xenopus laevis | 2019 |
Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
Topics: Animals; Arginine; Benzazepines; Cues; Extinction, Psychological; Fear; Memory; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Time Factors | 2019 |
Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.
Topics: Animals; Arginine; Benzazepines; Body Weight; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Humans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Receptors, Neuropeptide Y | 2019 |
A role for NPY-NPY2R signaling in albuminuric kidney disease.
Topics: Albuminuria; Animals; Arginine; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Doxorubicin; Humans; Insulin; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neuropeptide Y; Podocytes; Proteomics; Receptors, Neuropeptide Y; Signal Transduction | 2020 |
Neuropeptide Y and glutamatergic mechanisms in the amygdala and ventral hippocampus differentially mediate impaired social behavior in diabetic mice.
Topics: Animals; Arginine; Basolateral Nuclear Complex; Behavior, Animal; Benzazepines; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Excitatory Amino Acid Antagonists; Hippocampus; Male; Mice; Mice, Inbred ICR; Neuropeptide Y; Receptors, AMPA; Receptors, Neuropeptide Y; Social Behavior | 2021 |
Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
Topics: Amygdala; Animals; Arginine; Benzazepines; Fear; Male; Mice; Neuropeptide Y; Phobia, Social; Receptors, Neuropeptide Y; Septum of Brain | 2021 |
Restraint stress potentiates neuropeptide Y-mediated impairment on spatial memory in rats.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Disease Models, Animal; Male; Memory Disorders; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Restraint, Physical; Spatial Memory; Stress, Psychological | 2022 |